Clinical Trials Browser

Phase 1/2 × Interventional × Gynecological Cancer × Clear all

NCT04236362 2021-01-12

A Study of TQB2450 Combined With Anlotinib in Subjects With Gynecological Cancer

Phase 1/2 Unknown

Gynecological Cancer